Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-19

Clinical Trial Update: Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus [Phase 2]

View source ↗

Summary

Clinical trial update on the safety and tolerability of difelikefalin in adolescents on haemodialysis with moderate-to-severe pruritus. The Phase 2 study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Difelikefalin (difelikefalin)

Snippet

Sponsor: Vifor Fresenius Medical Care Renal Pharma | Conditions: Pruritus, Chronic Kidney Diseases | Phase 2 | Status: RECRUITING